is retatrutide fda approved october 2025 TRIUMPH-4: Beat Every Prediction (Full Data) October 27, 2025: U.K. regulators

According to FDA prescribing information, approximately 20% of participants experience gastrointestinal side effects with either medication, while 60-75% of patients report at least one adverse event of any type

Supplementen met stoffen die GLP-1 zouden ondersteunen, zijn geen geregistreerde geneesmiddelen

Download a copy of my digital health startup database

Im very pro GLP-1s

After months of reduced hunger, this new normal no longer registers as noteworthy

The SAFE Drugs Act, introduced in December 2025, would expand the FDA's power over compounded and unregulated GLP-1 products and the telehealth companies that prescribe them (Dykema analysis)